• SENSEX 81,444.66
    -138.64 (--0.17%)
  • BANKNIFTY 55,714.15
    -230.75 (--0.41%)
  • Hindustan Zinc
    451.50 378.65(%)
  • Garden Reach Sh.
    3,286.00 3,528.00(%)
  • NTPC
    330.65 292.70(%)
  • Vishal Mega Mart
    121.90 96.05(%)
  • Optiemus Infra.
    706.50 873.65(%)
  • Infosys
    1,615.00 1,307.10(%)
  • IndusInd Bank
    855.20 1,550.00(%)
  • Cochin Shipyard
    2,135.60 1,180.45(%)
  • Reliance Power
    66.85 76.49(%)
  • Electronics Mart
    161.25 261.75(%)
  • Sika Interplant
    1,537.30 1,485.35(%)
  • Sterlite Tech.
    101.50 50.70(%)
  • Tata Motors
    668.00 542.55(%)
  • Sky Gold & Diam.
    344.60 126.59(%)
  • Wockhardt
    1,699.55 552.20(%)
  • S C I
    225.85 384.80(%)
  • Mazagon Dock
    3,237.70 1,917.95(%)
  • Reliance Industr
    1,425.55 1,115.55(%)
  • HDFC Bank
    1,935.70 1,996.30(%)
  • Suzlon Energy
    63.80 46.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Shilpa Medicare Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 5031.0
  • ISIN : INE790G01031
934.40 -49 (-5.00%)
  • As on 18 Jun 2025 (EOD)

  • Today’s Low

    934.40

  • Today’s High

    990.00

  • Open

    990.00

  • Perv Close

    983.55

  • 52W Low

    519.50

  • 52W High

    1,000.00

Key Indicators

  • P/E(TTM)

    95.54

  • Mar.Cap (₹Cr.)

    9,137.58

  • Div & Yield %

    0.11

  • Book Value(₹)

    276.16

  • Debt-Equity Ratio

    -5.00

  • AGM Date

    17-Jun-2025

  • EPS

    9.76

  • P/E Ratio

    95.54

Financials Ratios

  • Debt-Equity Ratio

    0.48

  • Mar.Cap (₹Cr.)

    9,137.58

  • RONW (%)

    1.72

  • ROCE (%)

    5.16

Score Board

  • Equity (₹ in Cr.)

    9.78

  • BV (₹)

    276.20

  • Sales( ₹ in Cr.)

    477.34

  • NP (in Cr.)

    95.46

  • NP Var(%)

    182.0

  • Div%

    100.0

  • CPS (₹)

    14.80

  • EPS (₹)

    9.80

  • Traded Value (₹ in Lakhs)

    9,118.51

  • 52 Week High

    1,000.00

  • 52 Week Low

    519.50

  • Price BSE

    932.0

  • Price NSE

    934.00

  • Market Capital( in Cr.)

    9,118.51

  • P/C Ratio

    63.20

  • P/E Ratio

    95.50

  • Price Vs.BV

    9.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 309.79 247.70 356.95 257.05 805.97 663.88
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 309.79 247.70 356.95 257.05 805.97 663.88
Other Income 89.12 175.32 170.50 204.49 36.79 41.73
Stock Adjustments -2.63 -4.08 3.18 10.26 14.26 9.92
Total Income 396.28 418.94 530.63 471.80 857.02 715.53
EXPENDITURE :            
Raw Materials 86.62 78.12 81.96 69.37 279.83 244.80
Power and Fuel Cost 18.73 18.70 17.47 12.42 35.31 31.39
Employee Cost 103.64 109.54 110.57 76.10 149.28 124.66
Other Manufacturing Expenses 15.32 18.28 22.79 16.71 35.94 34.12
Selling and Administration Expenses 49.74 60.03 106.22 55.92 67.02 39.32
Miscellaneous Expenses 17.26 18.50 -0.57 3.43 12.50 42.60
Employee Benefit Expenses 103.64 109.54 110.57 76.10 149.28 124.66
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 291.31 303.17 338.44 233.95 579.87 516.87
Operating Profit 104.96 115.78 192.18 237.86 277.15 198.66
Interest 17.26 20.83 9.05 6.07 4.33 2.79
Gross Profit 87.70 94.95 183.13 231.79 272.82 195.87
Depreciation 49.61 46.55 34.82 22.28 34.96 34.01
Profit Before Tax 38.09 48.40 148.31 209.51 237.86 161.86
Current Tax 11.29 -8.37 4.80 15.78 39.09 40.50
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.13 -0.43 2.53 9.34 5.05 -2.76
Reported Net Profit 26.94 57.19 140.99 184.39 193.72 124.11
Extraordinary Items -6.93 -15.86 8.23 46.40 -3.65 6.89
Adjusted Net Profit 33.87 73.05 132.76 137.99 197.37 117.22
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 1,332.11 1,284.46 1,152.44 968.05 794.97 670.87
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 9.55 8.97 0.00 20.64 0.00
P & L Balance carried down 1,359.05 1,332.11 1,284.46 1,152.44 968.05 794.97
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 110.00 110.00 110.00 100.00
Dividend Per Share(Rs) 0.00 0.00 1.10 1.10 1.10 1.00
Earnings Per Share-Unit Curr 3.10 6.59 16.24 22.62 23.76 15.22
Earnings Per Share(Adj)-Unit Curr 3.10 6.59 16.24 22.62 23.76 15.22
Book Value 246.85 243.96 237.97 200.89 178.27 157.19
Book Value(Adj)-Unit Curr 246.85 243.96 237.97 200.89 178.27 157.19

Shareholding Pattern

  • Promoter Group

    44.23%

  • Public Share Holding

    55.77%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 43,249,715 44.23 43,249,715 23
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 43,249,715 44.23 43,249,715 23
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 502 0.00 502 2
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 10,729,110 10.97 10,729,110 98
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 1,500 0.00 1,500 1
Insurance Companies 2,029,765 2.08 2,029,765 2
Mutual Funds / UTI 3,960,141 4.05 3,960,141 8
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,390,349 1.42 1,390,349 10
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 18,111,367 18.52 18,111,367 121
2] Non Institution
Bodies Corporate 10,587,149 10.83 10,587,149 551
Clearing Members 58,016 0.06 58,016 3
Directors of their Relatives 31,075 0.03 31,075 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 811,955 0.83 811,955 988
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 770,412 0.79 770,412 1,128
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 7,892,396 8.07 7,892,396 14
Individuals holding nominal share capital up to Rs. 1 lakh 15,993,466 16.35 15,858,202 47,272
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 2,106 0.00 2,106 4
Others 283,251 0.29 283,251 2
Sub Total 36,429,826 37.25 36,294,562 49,964
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 97,790,908 100.00 97,655,644 50,108

Company Background

Shilpa Medicare LtdPharmaceuticals - Indian - Formulations

  • Shilpa Medicare Ltd
  • BSE Code : 5031.0
  • ISIN : INE790G01031

  • Incorporation Year

    1987

  • Registered Office

    #12-6-214/A1
    Hyderabad Road, Raichur,
    Karnataka-584135

  • Telephone

    91-8532-238704

  • FAX

    91-8532238876

  • Chairman

    Omprakash Inani

  • Managing Director

    Vishnukant Bhutada

  • Company Secretary

    Ritu Tiwary

  • Auditor

    Bohara Bhandari Bung And Associates LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Shilpa Medicare Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Shilpa Medicare 932.45 398.90 309.79 130.60 2.77
Abbott India 31,803.35 6,097.18 5,848.91 47.78 44.71
Astrazeneca Phar 10,081.60 1,330.33 1,295.53 217.75 33.26
P & G Health Ltd 5,907.05 1,166.89 1,151.26 39.04 39.76
Glaxosmi. Pharma 3,252.30 3,866.05 3,723.49 59.95 58.72
Cipla 1,503.50 17,645.00 16,574.34 23.54 20.10
Amrutanjan Healt 708.25 437.58 421.23 40.29 20.84
Guj. Themis Bio. 337.05 174.19 169.82 75.23 44.82
Fermenta Biotec. 334.25 315.24 307.09 14.55 4.10
Bliss GVS Pharma 141.95 638.96 605.46 21.67 11.19
Ambalal Sarabhai 36.76 11.70 3.81 34.04 1.92